Ralexar Therapeutics

Ralexar Therapeutics, Inc., headquartered in Wayne, Pennsylvania, is a privately held specialty pharmaceutical company founded in January 2014. The company is developing both topical and systemic treatments based on Liver X Receptor (LXR) modulators. Its initial focus is on the clinical development of ALX-101, an LXR-based topical treatment for various inflammatory skin conditions, including atopic dermatitis.